BioPorto
BIOPOR Nasdaq Copenhagen
LEI 5299004SWFL5JAN4W830
Follow BioPorto
Weekly email: filings, results
Revenue, last year
DKK 40.3M
Net income
−DKK 82.1M
EPS, diluted
−DKK 0.18
Operating cash flow
−DKK 77.1M
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | DKK 40.3M | −DKK 82.1M |
| FY25 | - | - |
| FY24 | DKK 36.2M | −DKK 68.2M |
| FY23 | DKK 31M | −DKK 56.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 75.4% | −213.7% | −203.8% |
| FY25 | - | - | - |
| FY24 | 67.7% | −208.2% | −188.3% |
| FY23 | 65.2% | −197.6% | −181.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −DKK 77.1M |
| FY25 | - |
| FY24 | −DKK 83.9M |
| FY23 | −DKK 55.5M |